170 related articles for article (PubMed ID: 34478828)
21. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
22. Peiminine Protects Dopaminergic Neurons from Inflammation-Induced Cell Death by Inhibiting the ERK1/2 and NF-κB Signalling Pathways.
Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Liu D; Fu S
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534526
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective Effects of Intranasal IGF-1 against Neonatal Lipopolysaccharide-Induced Neurobehavioral Deficits and Neuronal Inflammation in the Substantia Nigra and Locus Coeruleus of Juvenile Rats.
Tien LT; Lee YJ; Pang Y; Lu S; Lee JW; Tseng CH; Bhatt AJ; Savich RD; Fan LW
Dev Neurosci; 2017; 39(6):443-459. PubMed ID: 28787734
[TBL] [Abstract][Full Text] [Related]
24. Kaemperfol alleviates pyroptosis and microglia-mediated neuroinflammation in Parkinson's disease via inhibiting p38MAPK/NF-κB signaling pathway.
Cai M; Zhuang W; Lv E; Liu Z; Wang Y; Zhang W; Fu W
Neurochem Int; 2022 Jan; 152():105221. PubMed ID: 34780806
[TBL] [Abstract][Full Text] [Related]
25. Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models.
Huang B; Liu J; Ju C; Yang D; Chen G; Xu S; Zeng Y; Yan X; Wang W; Liu D; Fu S
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937602
[TBL] [Abstract][Full Text] [Related]
26. Diosgenin Prevents Microglial Activation and Protects Dopaminergic Neurons from Lipopolysaccharide-Induced Neural Damage In Vitro and In Vivo.
Lee SL; Tu SC; Hsu MY; Chin TY
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638697
[TBL] [Abstract][Full Text] [Related]
27. Curcumin protects dopaminergic neurons against inflammation-mediated damage and improves motor dysfunction induced by single intranigral lipopolysaccharide injection.
Sharma N; Sharma S; Nehru B
Inflammopharmacology; 2017 Jun; 25(3):351-368. PubMed ID: 28409389
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor-β1 acts via TβR-I on microglia to protect against MPP(+)-induced dopaminergic neuronal loss.
Liu Z; Chen HQ; Huang Y; Qiu YH; Peng YP
Brain Behav Immun; 2016 Jan; 51():131-143. PubMed ID: 26254549
[TBL] [Abstract][Full Text] [Related]
29. Erinacine A Prevents Lipopolysaccharide-Mediated Glial Cell Activation to Protect Dopaminergic Neurons against Inflammatory Factor-Induced Cell Death In Vitro and In Vivo.
Lee SL; Hsu JY; Chen TC; Huang CC; Wu TY; Chin TY
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054997
[No Abstract] [Full Text] [Related]
30. Triptolide up-regulates metabotropic glutamate receptor 5 to inhibit microglia activation in the lipopolysaccharide-induced model of Parkinson's disease.
Huang YY; Zhang Q; Zhang JN; Zhang YN; Gu L; Yang HM; Xia N; Wang XM; Zhang H
Brain Behav Immun; 2018 Jul; 71():93-107. PubMed ID: 29649522
[TBL] [Abstract][Full Text] [Related]
31. Biochanin A attenuates LPS-induced pro-inflammatory responses and inhibits the activation of the MAPK pathway in BV2 microglial cells.
Wu WY; Wu YY; Huang H; He C; Li WZ; Wang HL; Chen HQ; Yin YY
Int J Mol Med; 2015 Feb; 35(2):391-8. PubMed ID: 25483920
[TBL] [Abstract][Full Text] [Related]
32. The beneficial effect of salubrinal on neuroinflammation and neuronal loss in intranigral LPS-induced hemi-Parkinson disease model in rats.
Cankara FN; Kuş MS; Günaydın C; Şafak S; Bilge SS; Ozmen O; Tural E; Kortholt A
Immunopharmacol Immunotoxicol; 2022 Apr; 44(2):168-177. PubMed ID: 35021949
[TBL] [Abstract][Full Text] [Related]
33. Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.
Gómez-Gálvez Y; Palomo-Garo C; Fernández-Ruiz J; García C
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():200-8. PubMed ID: 25863279
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models.
Tai W; Ye X; Bao X; Zhao B; Wang X; Zhang D
Neuropharmacology; 2013 Dec; 75():201-12. PubMed ID: 23916477
[TBL] [Abstract][Full Text] [Related]
35. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
[TBL] [Abstract][Full Text] [Related]
36. PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease.
Quesada A; Lee BY; Micevych PE
Dev Neurobiol; 2008 Apr; 68(5):632-44. PubMed ID: 18278798
[TBL] [Abstract][Full Text] [Related]
37. Tangeretin exerts anti-neuroinflammatory effects via NF-κB modulation in lipopolysaccharide-stimulated microglial cells.
Shu Z; Yang B; Zhao H; Xu B; Jiao W; Wang Q; Wang Z; Kuang H
Int Immunopharmacol; 2014 Apr; 19(2):275-82. PubMed ID: 24462494
[TBL] [Abstract][Full Text] [Related]
38. Steppogenin Isolated from Cudrania tricuspidata Shows Antineuroinflammatory Effects via NF-κB and MAPK Pathways in LPS-Stimulated BV2 and Primary Rat Microglial Cells.
Kim DC; Quang TH; Oh H; Kim YC
Molecules; 2017 Dec; 22(12):. PubMed ID: 29207498
[TBL] [Abstract][Full Text] [Related]
39. Bear bile powder alleviates Parkinson's disease-like behavior in mice by inhibiting astrocyte-mediated neuroinflammation.
Wang L; Bai Y; Tao Y; Shen W; Zhou H; He Y; Wu H; Huang F; Shi H; Wu X
Chin J Nat Med; 2023 Sep; 21(9):710-720. PubMed ID: 37777320
[TBL] [Abstract][Full Text] [Related]
40. Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection.
Zhou HF; Liu XY; Niu DB; Li FQ; He QH; Wang XM
Neurobiol Dis; 2005 Apr; 18(3):441-9. PubMed ID: 15755670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
